Chemiluminescent immunoassay (CLIA) is an immunoassay technique where the label, i.e. the true "indicator" of the analytic reaction, is a luminescent molecule.
North America is the largest consumption place, with a consumption market share nearly 38.2% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.7%.
Market competition is not intense. Roche Diagnostics, Abbott, Danaher, Siemens Healthcare, Johnson & Johnson, Snibe, DiaSorin, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
According to this study, over the next five years the Automatic Chemiluminescence Immunoassay Analyzer market will register a 7.6% CAGR in terms of revenue, the global market size will reach US$ 3190 million by 2024, from US$ 2210 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Automatic Chemiluminescence Immunoassay Analyzer business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Automatic Chemiluminescence Immunoassay Analyzer market by product type, application, key manufacturers and key regions and countries.
This study considers the Automatic Chemiluminescence Immunoassay Analyzer value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Enhanced Chemiluminescence
Chemiluminescence
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche Diagnostics
Abbott
Danaher
Siemens Healthcare
Johnson & Johnson
Snibe
DiaSorin
Luminex Corporation
Leadman Biochemistry
Maccura
Autobio Diagnostics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Automatic Chemiluminescence Immunoassay Analyzer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Automatic Chemiluminescence Immunoassay Analyzer market by identifying its various subsegments.
Focuses on the key global Automatic Chemiluminescence Immunoassay Analyzer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Automatic Chemiluminescence Immunoassay Analyzer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Automatic Chemiluminescence Immunoassay Analyzer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
